Skip to main content

Sharoky Melvin MD's Form 4 filing

INSMED Inc (INSM) · filed Sep 15, 2025

Accession no.
0001182633-25-000013
Filed
Sep 15, 2025
Trade date
Sep 11-12, 2025
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions. Open-market sales total $1.45M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sharoky Melvin MDCIK 0001182633Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 11, 2025Common StockGGiftDisposed−2,000$0.00$0272,516Direct
Sep 11, 2025Common StockGGiftDisposed−159$0.00$0741Indirect
Sep 11, 2025Common StockGGiftAcquired+159$0.00$0272,675Direct
Sep 12, 2025Common StockSSaleDisposed−10,000$145.39F2−$1,453,900262,675Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This is the weighted average sales price representing 10,000 shares sold at prices ranging from $145.36 to $145.46 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)